Clinical trial
Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome
NCT00233363 · Otsuka Pharmaceutical Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00233363 |
|---|---|
| Title | Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome |
| Official title | An Exploratory Study of Rebamipide to Evaluate Efficacy and Safety in the Treatment of Dry Mouth in Patients With Sjögren's Syndrome |
| Lead sponsor | Otsuka Pharmaceutical Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Xerostomia, Sjogren's Syndrome |
| Intervention type | Drug |
| Interventions | Rebamipide |
| Enrollment | 104 |
| Start date | Apr 15, 2005 |
| Primary completion | Jan 19, 2006 |
| Completion | Jan 27, 2006 |
| First posted | Oct 5, 2005 |
| Last update posted | Jun 4, 2021 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: